Back to results
CompletedPhase 2

Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease

NCT03459079

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

University of Florida

Gainesville, Florida, United States

View on ClinicalTrials.gov
Lanifibranor in Patients With Type 2 Diabetes & Nonalcoholic Fatty Liver Disease — TrialFind